cp wire

CP Wire Articles

Allogene Therapeutics Banks $120 Million in Private Financing
  • Allogene completed a $300 Million Series A round in April of 2018
  • Investors in the Series A round included Gilead and Pfizer


Allogene Therapeutics, Inc., a clinical-... read more

Thu, 09/6/18 - 09:37 am
admin
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
  • VX-659 and VX-445 are next gen correctors
  • Correctors fix the defective CFTR protein so that it can move to the proper place on the cell surface
  • Vertex expects to submit an... read more
Thu, 09/6/18 - 09:20 am
admin
[sponsored] Orange Book Companion® Adds New Features and Capabilities

Historical patent and exclusivity data for FDA-approved drugs now available

Hillsborough, New Jersey – September 5, 2018 – Bruce Pokras’ ... read more

Wed, 09/5/18 - 01:34 pm
admin
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
  • Lenvima is the first new systemic therapy approved for the first-line treatment of unresectable HCC in China in ten years
  • In China, there are approximately 395,000 new cases of liver... read more
Wed, 09/5/18 - 09:24 am
admin
FDA Approves Clinical Trial of Tuberculosis Vaccine for Fibromyalgia

EpicGenetics announced on9/5/18 that the U.S. Food and Drug Administration (FDA) has given approval to the Massachusetts General Hospital for a human clinical trial of BCG (an inexpensive generic... read more

Wed, 09/5/18 - 09:08 am
admin
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors

Seres Therapeutics, Inc. (Nasdaq:MCRB) today announced the appointment of Meryl Zausner, a seasoned biopharmaceutical executive, to its Board of Directors. Ms. Zausner brings decades of financial... read more

Tue, 09/4/18 - 10:02 am
admin
LEO Pharma Closes Acquisition of Bayer’s Prescription Dermatology Business in the US

LEO Pharma and Bayer announced today the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States.... read more

Tue, 09/4/18 - 09:55 am
admin
Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases

  • Many pathogens may inhibit or modulate their host’s immune system and thus circumvent immune defense
  • Immune system activating therapies may open transformative opportunities... read more
Tue, 09/4/18 - 09:44 am
admin
On the Heels of $20 Million Funding Round, Macrolide Adds Scientific and Financial Expertise

Macrolide Pharmaceuticals announced on 9/4/18 a leadership expansion that adds significant expertise in drug development, clinical strategy, finance and... read more

Tue, 09/4/18 - 09:28 am
admin
Sunovion Receives Bad News From the FDA About ADHD Drug


Sunovion Pharmaceuticals Inc. (Sunovion) announced on 8/31/18 that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application (NDA) for... read more

Fri, 08/31/18 - 10:42 am
admin
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia


Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental Biologics License Application (sBLA) for Sprycel (dasatinib... read more

Thu, 08/30/18 - 09:44 am
CP Staff
Pfizer Ends Trials for Domagrozumab in Drug for Duchenne Muscular Dystrophy
  • Domagrozumab Ph II study did not meet primary endpoint
  • Pfizer is also developing a gene therapy, PF-06939926, for DMD
  • PF-06939926 has orphan status in the US and Europe... read more
Thu, 08/30/18 - 09:31 am
CP Staff
Trovagene Receives Orphan Drug Designation for Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
  • Onvansertib also has orphan status in the US
  • Onvansertib has the potential to improve clinical efficacy in Acute Myeloid Leukemia (AML), metastatic Castration-Resistant Prostate... read more
Wed, 08/29/18 - 12:24 pm
CP Staff
Microbiome Report for Week Ending 8/25/18

Kaleido Biosciences Promotes Industry Veteran to CEO Role... read more

Wed, 08/29/18 - 12:02 pm
CP Staff
Study Shows Unequivocal Gastrointestinal Safety of Antibe's ATB-346 compared to Naproxen
  • ATB-346 is a hydrogen sulfide-releasing derivative of naproxen
  • H2s has been shown to play important role in the maintenance of gastric mucosal integrity.


... read more

Wed, 08/29/18 - 09:57 am
CP Staff
Omeros Receives Orphan Designation in Europe for Treatment in Hematopoietic Stem Cell Transplantation
  • OMS721 is also being studied in atypical hemolytic uremic syndrome, IgA nephropathy, and lupus nephritis
  • The drug also has orphan status for the treatment of primary IgA nephropathy... read more
Tue, 08/28/18 - 11:53 am
CP Staff
ReflectionBio Receives Orphan Drug Designation For Rare Eye Disease



Reflection Biotechnologies Limited ("ReflectionBio") announced on 8/28/18 that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ReflectionBio's RBIO-101... read more

Tue, 08/28/18 - 09:20 am
CP Staff
Bio-Path Doses First Patient in Ph II Expansion Trial in Acute Myeloid Leukemia

  • The primary objective of the study is to determine whether the combination of prexigebersen and LDAC provides greater efficacy than would be expected with LDAC alone... read more

Mon, 08/27/18 - 09:49 am
CP Staff
Magnolia Neurosciences Receives $20 Million CPRIT Grant to Develop Therapies to Treat Chemotherapy-Induced Neurological Conditions


Magnolia Neurosciences Corporation (Magnolia) announced on 8/27/18 that Korysso Therapeutics, Inc. (DBA: Magnolia Tejas Corporation), the company’s wholly owned, Houston-based subsidiary, has... read more

Mon, 08/27/18 - 09:22 am
CP Staff
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis

LifeMax Laboratories, Inc. (“LifeMax”) announced on 8/27/18 an exclusive worldwide license from Novartis Pharma AG for the right to develop, manufacture and commercialize BPR277, a clinical stage... read more

Mon, 08/27/18 - 09:12 am
CP Staff

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.